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Abstract
Understanding the biological function behind key proteins is of great concern in Atlantic salmon, both due to a high
commercial importance and an interesting life history. Until recently, functional studies in salmonids appeared to be
difficult. However, the recent discovery of targeted mutagenesis using the CRISPR/Cas9 (clustered regularly interspaced
palindromic repeats/CRISPR-associated) system enables performing functional studies in Atlantic salmon to a great extent.
We used the CRISPR/Cas9 system to target two genes involved in pigmentation, tyrosinase (tyr) and solute carrier family 45,
member 2 (slc45a2). Embryos were assayed for mutation rates at the 17 somite stage, where 40 and 22% of all injected
embryos showed a high degree of mutation induction for slc45a2 and tyr, respectively. At hatching this mutation frequency
was also visible for both targeted genes, displaying a graded phenotype ranging from complete lack of pigmentation to
partial loss and normal pigmentation. CRISPRslc45a2/Cas9 injected embryos showing a complete lack of pigmentation or
just a few spots of pigments also lacked wild type sequences when assaying more than 80 (slc45a2) sequence clones from
whole embryos. This indicates that CRISPR/Cas9 can induce double-allelic knockout in the F0 generation. However, types
and frequency of indels might affect the phenotype. Therefore, the variation of indels was assayed in the graded
pigmentation phenotypes produced by CRISPR/Cas9-slc45a2. The results show a tendency for fewer types of indels formed
in juveniles completely lacking pigmentation compared to juveniles displaying partial pigmentation. Another interesting
observation was a high degree of the same indel type in different juveniles. This study shows for the first time successful use
of the CRISPR/Cas9 technology in a marine cold water species. Targeted double-allelic mutations were obtained and,
though the level of mosaicism has to be considered, we demonstrate that F0 fish can be used for functional studies in
Atlantic salmon.
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Introduction
Atlantic salmon is an important commercial aquaculture
species. Likewise, the growing salmon industry displays a demand
for healthy, fast growing and tasty fish. To improve knowledge and
to solve bottlenecks of salmon aquaculture, the salmon genome is
currently being sequenced [1]. To further implement findings
gained from the salmon genome, functional studies of genes linked
to health, growth, welfare and filet quality will be necessary. This
will increase our knowledge and possibly explain causative
relations to some of the challenges present in the aquaculture
industry such as egg/sperm quality, reproductive mechanisms,
growth rate, disease resistance and immunological mechanisms. In
the era of genome wide association studies many genes will be
directly linked to a trait and further functional characterization of
these genes will significantly improve selective breeding of
associated traits.
Functional studies in salmon embryos have so far been difficult
to implement, but a few studies have employed knockdown
techniques in salmonids using morpholinos [2–4]. However,
current approaches have not proven to be very efficient. This
can partly be ascribed to the characteristics of the egg being
difficult to precisely inject due to its large and opaque features and
almost invisible first cell stage [5]. This together with the variable
efficiencies using morpholinos makes it even more difficult in this
non-model species [6].
In recent years the ability to specifically create targeted
mutations by gene editing techniques has steadily improved. The
first gene editing experiments in teleosts were conducted in
zebrafish, starting with targeted mutagenesis using zinc finger
nucleases (ZFN, [7,8]) followed by the more efficient transcription
activator-like effectors (TALENS, [9]). A study in rainbow trout
used ZFN to induce targeted mutagenesis in the sdy gene, with the
purpose to confirm its function in sex determination [10]. The
ZFN technology has also been applied to a catfish species, with the
aim to elucidate muscle growth mechanisms [11]. The problem
using this methodology in salmonids is their long generation time
(2–4 years) as previously used targeted mutagenesis protocols do
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not efficiently induce bi-allelic mutations and therefore require
breeding for two more generations to induce a homozygous
mutation in targeted genes.
Recently, with the CRISPR (clustered regularly interspaced
palindromic repeats)/Cas9 (CRISPR-associated) system, a highly
efficient technology has been developed, which has shown to
specifically induce mutations in many model and non-model
animals including zebrafish and tilapia [12,13]. This technology is
so efficient in zebrafish and Xenopus that it can induce gene
specific bi-allelic mutations in the first (F0) generation [14,15].
This feature makes this new technology very promising for use in
non-model organisms with longer life spans such as the Atlantic
salmon.
The CRISPR/Cas9 system was identified in bacteria and
archaea, serving as an immune system against bacteriophages and
foreign DNA [16–19]. In these organisms the CRISPR loci
incorporates foreign DNA, this DNA is then synthesized into short
CRISPR RNAs (crRNA) which bind to a transactivating RNA
(tracrRNA) and to foreign DNA catalyzing cleavage and
destruction by recruiting the RNA-guided DNA nuclease Cas9
[20]. A construct which has been tailored for targeted mutations is
a fusion of crRNA and tracrRNA functioning as a guide RNA
(gRNA) which in combination with the Cas9 nuclease can then
induce double DNA strand breaks [21]. The mutation is
introduced when the doublestrand break is repaired by either
high-fidelity homologous recombination or error prone non-
homologous end-joining (NHEJ).
The aim of the present study was to attempt creating specifically
induced bi-allelic mutations in target genes in Atlantic salmon
using the CRISPR/Cas9 system. For this purpose we selected
genes producing pronounced pigmentation phenotypes in zebra-
fish enabling a direct visual enumeration [22–23]. Specific target
oligonucleotides corresponding to two genes (tyrosinase and
slc45a2) known to be involved in pigmentation in zebrafish and
other species were cloned into a CRISPR vector developed for
zebrafish [14]. In vitro transcribed RNAs from the cloned
constructs were injected into one-cell stage Atlantic salmon
embryos together with Cas9 mRNA. Mutation rates were
measured in whole embryos prior to hatch and in DNA prepared
from finclip versus whole juvenile fish showing lack of pigmenta-
tion. Here, we present the first targeted genome editing employing
the CRISPR/Cas9 technology on salmonid fish and further
extend the list of successfully tested non-model species where
functional studies and induction of mutations have previously been
problematic.
Materials and Methods
Cloning of target sites for gRNAs
Using a draft salmon genome sequence (AGKD00000000.1)
both tyrosinase (tyr) and slc45a2 exon sequences were predicted by
comparing to published sequences in salmon for tyr (Accession:
NM_001123643) and in zebrafish for slc45a2 (NP_001103847).
From the predicted sequences in the salmon genome the slc45a2
gene was found split into two contigs (Accession:
AGKD01080285, AGKD01048537). The salmon tyrosinase (tyr)
coding sequence was found split into four genomic contigs
(Accession: AGKD01095509, AGKD01379509,
AGKD01094529, AGKD01346345). Suitable oligonucleotides
for CRISPR targeting were selected using an online tool provided
by http://zifit.partners.org/ZiFiT/ [24]. Candidate target se-
quences were compared to the current salmon genome draft to
exclude unwanted off-target cleavage. Target site and oligonucle-
otide sequences for salmon slc45a2 and tyr are listed in Table S1.
Oligonucletides were annealed and cloned into pT7-gRNA [14],
Addgene ID# 46759 as described below: 2 mM of each forward
and reverse oligonucleotide was annealed in annealing buffer (0.4
M Tris pH 8, 0.2 M MgCl2, 0.5 M NaCl, 10 mM EDTA pH 8) by
incubating at 95uC for 5 min, followed by ramping down to 4uC at
22uC/min. 3 ml of annealed oligonucleotides were ligated into
5 ng of BsmBI, BglII, SalI digested pT7-gRNA and gel-extracted
using Quick T4 DNA Ligase (NEB) and subsequently cloned using
XL1-blue competent cells (Stratagene). Plasmids were prepared
using a QIAprep Spin Miniprep Kit (Qiagen).
In-vitro transcription of gRNA and Cas9 mRNA
pT7-gRNA was linearized using BamHI-HF (NEB), containing
the respective cloned target sites for either slc45a2 or tyr, were
prepared using a QIAprep column (Qiagen) and transcribed using
the MEGAscript T7 kit (Ambion) according to the manufacturer’s
protocol. The mirVana miRNA Isoltation Kit was used to purify
gRNAs.
For producing Cas9 nuclease mRNA, we used the pTST3-
nCas9n vector optimized for Zebrafish [14] (Addgene ID#
46757). Prior to in-vitro transcription, the plasmid was linearized
using XbaI (NEB) and cleaned up via a QIAprep Spin column.
Cas9 mRNA was produced using the mMessage mMachine T3 kit
(Ambion) and purified using an RNeasy MiniKit spin column
(Qiagen).
Injection procedures
Salmon eggs and sperm obtained from Aquagen (Trondheim,
Norway) were sent overnight to Matre Aquaculture station at
IMR. Eggs were subsequently fertilized with sperm in fresh water
(6–8uC) containing 0.5 mM reduced Gluthathione as described
earlier for rainbow trout [25]. After fertilization, embryos were
incubated 2–3 hours at 6–8uC until the first cell was visible. Eggs
were subsequently injected with a mix containing 50 ng/ml gRNA
and 150 ng/ml Cas9 mRNA in MilliQ H2O using the picospritzer
III (Parker Automation, UK) and needles from Narishige (Japan).
After injection, eggs were incubated at 6uC until hatching.
Analysis of mutations
DNA was obtained from embryos, juveniles and fin clips using
DNeasy Blood & Tissue kit (Qiagen) or AllPrep DNA/RNA kit
(Qiagen) with the following modifications: Eggs were squashed in
Buffer ATL and Proteinase K (DNeasy Blood & Tissue kit,
Qiagen), incubated at 56uC for 2–4 h and subjected to phenol/
chloroform extraction prior to DNA purification. Briefly, 1 vol. of
UltraPure Phenol/Chloroform/Isoamylalcohol (25:24:1, Life-
technologies) was added, mixed and phases separated by
centrifugation. The upper phase was mixed with 1 vol. of
chloroform, centrifuged and 1 vol. of Buffer AL and 100% EtOH
(DNeasy Blood & Tissue kit, Qiagen) was added to the DNA
containing aqueous phase and subjected to subsequent steps of the
DNeasy Blood & Tissue kit protocol. Juveniles (separated from the
yolk sac) and fin clips were homogenized using Zirconium oxide
beads and a homogenizer (Precellys) in buffer ATL or buffer
RLTplus/b-mercaptoethanol (AllPrep kit, Qiagen) prior to DNA
extraction. PCR was performed on genomic DNA to obtain a
fragment that covered the targeted mutagenesis site (PCR primer
sequences are listed in Table S1). Fragments were both directly
sequenced and subcloned into pCR4-TOPO using the TOPO TA
cloning kit for sequencing (Invitrogen) to either measure the
general effect in the target site in the whole preparation or in single
sequences from clones to assess the level of mosaic mutation rate in
each individual or sample.
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Ethics statement
All animal experiments within the study were approved by
NARA, the governmental Norwegian Animal Research Authority
(http://www.fdu.no/fdu/). To avoid unnecessary pain all fish
larvae were sedated with metomidate prior to sampling.
Results and Discussion
For the establishment of the CRISPR/Cas method in salmon,
target genes were selected based on their known role in
pigmentation of fish, as a resulting phenotype is clearly visible at
early developmental stages and throughout life. Since salmonid
Figure 1. Graded levels of phenotypes induced by CRISPRslc45a2/Cas9 (slc45a2-1 to slc45a2-3) and CRISPRtyr/Cas9 (tyr-1 to tyr-3)
found in picture A. Mutation rates and number of indel variants found in Atlantic salmon whole juvenile fish extracts at 650 dayu (B).
doi:10.1371/journal.pone.0108622.g001
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genomes are partly tetraploid [26], the two selected pigmentation
genes, tyrosinase and slc45a2, were also chosen because both
occur only once in the genome making them suitable for gene
knockout. Tyrosinase (tyr) is essential for normal pigmentation
both in medaka [27–28] and zebrafish [22]. In addition Tyr has
previously been shown to affect pigmentation in rainbow trout
using morpholinos [29]. Likewise, Slc45a2 is essential for
pigmentation in both zebrafish [23] and medaka [30].
Since development is relatively slow in Atlantic salmon, it takes
almost three months until a visible pigmentation phenotype can be
observed in hatched embryos at about 500 dayu (,84 days at 6uC
[5]). In salmon, the developmental stage is calculated as dayu by
multiplying the incubation temperature (in uC) with the amount of
days since fertilization. At stages prior to visual examination,
embryos can be screened by PCR for targeted mutations.
Consequently, injected embryos were harvested two weeks after
fertilization (17 somite stage, 72 dayu), DNA was extracted from
whole embryos and PCR screenings were performed for both
gRNA targets, CRISPRslc45a2/Cas9 (n = 20 embryos) and
CRISPRtyr/Cas9 (n= 9 embryos). This analysis revealed that
both CRISPRslc45a2/Cas9 and CRISPRtyr/Cas9 resulted in
induced mutations in 40% and 22% of the embryos at early
developmental stages, respectively (see Table 1). This reflects that
in our experiments the overall mutation rate is lower than what
has been observed in zebrafish (75–90%) [14] but within a similar
range as it has been obtained for tilapia (24–50%) [13]. A possible
reason for a lower mutation rate in Atlantic salmon can be the
lower incubation temperature (6–8uC) causing the Cas9 enzyme to
Table 1. Mutation rate in CRISPR/Cas9 embryos and juveniles.
Targeted Gene
17 somite stage
embryos (72 dayu) Phenotype 650 dayu
Mutants without
phenotype 650 dayu
slc45a2 40% (8/20) 8.7 % (16/184) 9.5% (2/21)
tyr 22 % (2/9) 5.1% (19/371) 45% (5/11)
doi:10.1371/journal.pone.0108622.t001
Figure 2. Level of indel abundances in fin clip versus whole juvenile DNA preparation from CRISPRslc45a2/Cas9 (slc45a2-4 to slc45a2-
6) at 600 dayu. (A) Fish analyzed for indels in fin clip and whole juvenile fish preparations. (B–D) Frequency [%] (x-axis) of a specific indel (y-axis) in
fin clip (grey bars) and whole fish (black bars) of Atlantic salmon juveniles at 600 dayu.
doi:10.1371/journal.pone.0108622.g002
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be less effective. Another more plausible explanation is the
injection procedure. Because of the opaque character of newly
fertilized salmon eggs and the hardness of the chorion it is difficult
to inject directly into the cytoplasm of the first cell. Therefore, the
relatively low number of embryos displaying mutations is possible
due to failed injections. However, we assume that successful
injections result in a high incidence of mutations (Figure 1 and 2)
which implies that the mutation efficiency is as high as previously
observed for zebrafish [14]. An increased early mutation
frequency could possibly also be obtained by injecting the Cas9
protein directly or by improving the timing of injection after
fertilization. It has been shown that the introduction of off-target
mutations might constitute a problem using the CRISPR/Cas9
system. In this study we did not measure off-target mutations,
however previous studies in zebrafish has shown a low off-target
mutation frequency produced by CRISPR [31]. CRISPR sites
were also carefully selected in this study to prevent off-target
effects.
At 650 dayu phenotypes in mutated juvenile groups were
visually determined and 8.7% and 5.1% of juveniles displayed a
graded loss of pigmentation (Figure 1A). The similar graded
degree of phenotype induction has previously been observed in
both zebrafish and Xenopus for targeting the tyr gene in these
species [14,32]. In contrast to these studies a dose dependent
severety of phenotype could not be established, since we only used
one empirically determined concentration of gRNA and Cas9
mRNA in our work. However, we cannot exclude a dose-
dependent effect due to injection procedures as explained above.
Fish showing a graded phenotype due to mutations in either
slc45a2 or tyr, were selected based on the level of pigmentation
loss. Hence, the following juveniles were subjected to PCR
screening and sequencing of induced mutations; full (slc45a2-1),
almost full (tyr-1), medium (slc45a2-2, tyr-2) and little pigmenta-
tion loss (slc45a2-3, tyr-3, Figure 1, Table S2a–c and S3a–c).
Additionally, two fish from each group, targeted for either slc45a2
or tyr, which showed no visual pigmentation loss were analyzed
(neg slc45a2#1, neg slc45a2#2, neg tyr#1 and neg tyr#2, Figure 1,
Table S2e–f and S3e–f). To quantify mutation frequencies in each
juvenile fish, DNA was extracted from the whole fish, a PCR
product covering the CRISPR target site was amplified and the
product was subsequently subcloned (50–100 clones per fish). In
the mutated slc45a2-1 fish, which displayed a complete loss of
pigmentation, no wild type sequences could be detected in any of
the clones assayed (n= 88). However, medium pigmentation loss
phenotype in slc45a2-2 (Figure 1, Table S2b) mutated fish also
lacked wild type sequences even though 87 clones were sequenced.
Simply undersampling might be an explanation for this. Never-
theless, more wild type sequences have been detected in fish with
less severe phenotypes, while none or few could be found in strong
(no/medium pigmentation) phenotypes. This trend was also
observed in two of the five tyr phenotypes (tyr-1 and tyr-2), where
only one wild type sequence of 58 and 54 sequenced clones,
respectively, could be detected in each fish (Figure 1, Table S3a–
b). Additionally, we screened 21 and 11 fish targeted for either
slc45a2 or tyr, displaying a wild type phenotype at 650 dayu (neg
slc45a2#1, neg slc45a2#2, neg tyr#1 and neg tyr#2, Figure 1B). In
these groups, 9,5% (slc45a2) and 45% (tyr) of juveniles were shown
to have indel mutations (Table 1, Table S2d–e and S3d–e). As
expected these fish displayed a low frequency of targeted
mutations explaining the wild type character of the fish
(Figure 1B).
We further wanted to know if embryo/juvenile stages could be
sorted based on mutation frequencies in fin clips only, instead of
sacrificing the whole fish. This is important in future studies when
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targeting genes with unknown function and where mutated
embryos/juveniles show no visual phenotype in F0. To investigate
if fin clips could mirror the mutation type found in whole fish, we
screened fin clip and whole fish DNA preparations from additional
juveniles (600 dayu) which displayed graded pigmentation
phenotypes in the slc45a2 knockout attempts. This included three
fish slc45a2-4 which only displayed a few pigmentation spots,
slc45a2-5 displayed some more pigmentation spots and slc45a2-6
displayed even more pigmentation spots (Figure 2A). These fish
were screened for indel types and frequencies which are presented
in Figure 2 B–D and in Table S4a–c. This comparison revealed
similar frequencies for the most common indel variants in all three
fish. However, among the less frequently occurring indels we
observe more indel variants in the whole fish compared to fin clip.
These results show that the fin clip to a certain degree mirrors the
mosaicism in the knockout fish and can therefore be used as a tool
to evaluate knockout phenotypes.
Another interesting finding was the independent generation of
the same mutation types in different fish injected with the same
gRNA (Table 2). By thorough screening of the 6 scl45a2 mutated
fish (slc45a2-1 to slc45a2-6, Figure 1A and 2A), we found 7 of the
indel variants to be present in at least three of the seven fish
(Table 2). However, we were not able to link the abundance of
certain indel types to specific phenotypes. These mutations were
all in proximity of the PAM site (bold and underlined in Table 2),
which is similar to what has been observed previously in zebrafish
[14,24]. A previous study using the CRISPR/Cas9 technology in
Xenopus also indicated that the same mutations were formed using
the same construct in different F0 individuals [15]. This further
suggests that individual F0 fish may hold the exact same indel
variants and crosses of these can produce a non mosaic
homozygous mutant already in the F1 generation. This technology
is therefore especially relevant for species with long generation
times like Atlantic salmon.
In conclusion, we show here for the first time successful targeted
mutagenesis in salmon using the CRISPR/Cas9 technology. We
anticipate that this technology will be an important tool for
functional studies in this biologically and commercially interesting
fish species. In the future the use of this technology will be
facilitated since the rainbow trout genome has recently been
sequenced [26] and the Atlantic salmon genome has been made
available (Acc. No. AGKD00000000.3). In our hands, genome
editing using CRISPR/Cas9 in salmon seems to be somewhat less
efficient than reported for other fish species [12–14], probably due
to the features of the egg and hence obstacles during injections
procedures. Nevertheless, using knockout of pigmentation genes as
shown here, can be a useful marker in co-injections with gRNAs
targeting other genes of interest which show no obvious
phenotype. This approach could facilitate the selection of putative
positive fish for confirming a successful knockout of targeted genes.
Previous targeted knock out technologies such as TALENs and
ZFN did induce lower mutation frequencies in the F0 compared to
CRISPR/Cas9 [7–9]. Hence, due to the general high efficiency
and biallelic mutation capacity of the CRISPR/Cas9 technology,
the F0 generation can already be used for the evaluation of protein
functions in salmonids, as has been previously demonstrated for
tilapia and Xenopus [13,15]. Furthermore, this paper substantiates
that the stronger the knockout phenotype found in the F0
generation is, the less indel variants are found. We also tested and
confirmed that fin clips can be used as an indicator of an efficient
knockout. To conclude, the establishment of functional studies
through the CRISPR/Cas9 technique in salmonids opens up new
doors to understand their basic biology and provides a useful tool
for investigating traits important for the aquaculture industry.
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